SCHEMBL8459576

SCHEMBL8459576

CC=CCC(=O)CCCCC

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FAAH O00519 5/20 0.50
MAPT P10636 3/20 0.50
KMT2A Q03164 2/20 0.50
CES2 O00748 4/20 0.48
CES1 P23141 4/20 0.48
AKR1B1 P15121 1/20 0.46
TERT O14746 3/20 0.45
BLM P54132 2/20 0.45
HSD17B10 Q99714 2/20 0.45
FABP4 P15090 2/20 0.45
PTPN1 P18031 2/20 0.45
PPARG P37231 2/20 0.45
PPARD Q03181 2/20 0.45
PPARA Q07869 2/20 0.45
GMNN O75496 1/20 0.45
USP2 O75604 1/20 0.45
LMNA P02545 1/20 0.45
CYP1A2 P05177 1/20 0.45
POLB P06746 1/20 0.45
CYP2C9 P11712 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8459575 1.00 FAAH (0.50) FAAHMAPTKMT2ACES2CES1
SCHEMBL8459328 0.98 MAPT (0.54) FAAHMAPTKMT2ACES2CES1
SCHEMBL4700430 0.98 MAPT (0.54) FAAHMAPTKMT2ACES2CES1
SCHEMBL8459329 0.98 MAPT (0.54) FAAHMAPTKMT2ACES2CES1
SCHEMBL8461565 0.93 CES1 (0.46) FAAHMAPTKMT2ACES2CES1
SCHEMBL6932381 0.93 CES1 (0.46) FAAHMAPTKMT2ACES2CES1
SCHEMBL6065110 0.84 FAAH (0.48) FAAHMAPTKMT2ACES2CES1
SCHEMBL4422607 0.84 FAAH (0.48) FAAHMAPTKMT2ACES2CES1
SCHEMBL6065108 0.84 FAAH (0.48) FAAHMAPTKMT2ACES2CES1
SCHEMBL10904137 0.84 KMT2A (0.52) FAAHMAPTKMT2ACES2CES1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0730590-A1 NOVEL ISOXAZOLINE AND ISOXAZOLE FIBRINOGEN RECEPTOR ANTAGONISTS THE DU PONT MERCK PHARMACEUTICAL COMPANY (US) 1996-09-11 EP claimed
US-11154475-B2 Method for coloring or bleaching hair fibers HERCULES LLC (US) 2021-10-26 US disclosed
WO-2020184272-A1 MODIFIED CARBON NANOMATERIAL, NANOCLUSTER, SUBSTANCE DELIVERY CARRIER AND PHARMACEUTICAL COMPOSITION 国立研究開発法人産業技術総合研究所 2020-09-17 WO disclosed
US-20180193242-A1 METHOD FOR COLORING OR BLEACHING HAIR FIBERS HERCULES LLC (DE) 2018-07-12 US disclosed
US-5961483-A Iontophoretic delivery of cell adhesion inhibitors COLLATERAL AGENTS, LLC 1999-10-05 US disclosed
US-5935598-A DEVICE FOR NON-INVASIVE ADMINISTRATION OF A CELL ADHESION RECEPTOR ANTAGONIST TO A MAMMAL; CURRENT DISTRIBUTING MEMBER, IONIZABLE ANTAGONIST RESERVOIR, ELECTROLYTE RESERVOIR, POWDER SOURCE; TREATING THROMBOSIS, ANTICOAGULANTS BECTON DICKINSON RESEARCH CENTER (US) 1999-08-10 US disclosed
US-5849736-A Isoxazoline and isoxazole fibrinogen receptor antagonists THE DUPONT MERCK PHARMACEUTICAL COMPANY (US) 1998-12-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180193242-A1 METHOD FOR COLORING OR BLEACHING HAIR FIBERS FHIT, KAT2B, KAT2A FAAH 115/4885MAPT 1644/4885KMT2A 433/4885
US-11154475-B2 Method for coloring or bleaching hair fibers FHIT, KAT2B, KAT2A FAAH 115/4885MAPT 1644/4885KMT2A 433/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.